Reports Q2 revenue $78.4B, consensus $81.04B. “Cencora (COR) delivered solid results in our second quarter as our team members continued to execute to meet the needs of our customers,” said Robert P. Mauch, President and Chief Executive Officer of Cencora. “Our fiscal 2026 guidance reflects the strength of our business and focus on our strategy to create long-term value. As we move into the second half of our fiscal year, we are pleased to have made progress on debt paydown and to be in a position to resume opportunistic share repurchases,” Mauch continued.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COR:
- Cencora lifts 2026 outlook after OneOncology-fueled earnings jump
- COR Upcoming Earnings Report: What to Expect?
- Analyst Maintains Hold on Cencora, Citing Strong Fundamentals but Better Risk‑Reward at McKesson and Cardinal Health
- Cencora initiated with a Market Perform at William Blair
- Cencora price target lowered to $360 from $420 at Evercore ISI